Skip to main content
 

Mediwhale

Mediwhale

Mediwhale is an innovative retina-based AI company that autonomously assesses cardiovascular disease risk. With a simple eye scan using fundus cameras, the company’s AI algorithm analyzes the blood vessels in the retinal images and generates a future cardiovascular disease risk with comparable performance to a heart CT scan within a minute, providing a safe, affordable, and accessible solution at the point of care. Mediwhale also expands the coverage from cardiovascular disease to renal and metabolic diseases.

More News

  • Masimo Joins Innovators’ Network at American Heart Association’s Center for Health Technology & Innovation

  • Still top cause of death, the types of heart disease people are dying from is changing

  • The Future of Brain Health – Where Technology Meets Neuroscience